Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
The Cancer Journal From Scientific American|February 19, 1998
Heterogeneity of drug resistance in human breast and ovarian cancersD H KernFamily Medicine|September 28, 2001
Disease management for diabetes among family physicians and general internists: opportunism or planned care?D H Kern, A G MainousOncology (Williston Park, N.Y.)|September 1, 1991
Prediction of drug resistance in cancer chemotherapy: the Kern and DiSC assaysL M Weisenthal, D H KernJournal of the National Cancer Institute|April 4, 1990
Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposuresD H Kern, L M WeisenthalIn Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|May 1, 1986
A rapid bioassay to determine stabilities of anticancer agents under conditions of the clonogenic assayS U Hildebrand-Zanki, D H KernGan No Rinsho. Japan Journal of Cancer Clinics|July 1, 1984
[Clinical correlations of drug sensitivity in the human tumor clonogenic assay--heterogeneity in drug sensitivity of human tumors]N Tanigawa, Y Hikasa, D H KernInternational Journal of Cell Cloning|September 1, 1987
In vitro assays for new drug screening: comparison of a thymidine incorporation assay with the human tumor colony-forming assayS U Hildebrand-Zanki, D H KernThe Cancer Journal From Scientific American|June 15, 1999
Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistanceJ W Orr, P Orr, D H KernThe Tokushima Journal of Experimental Medicine|June 1, 1992
Modulation of ganglioside expression in human melanoma cell lines; increased resistance to chemo- and radiation treatmentK Kunitomo, R F Irie, D H KernKlinische Wochenschrift|September 15, 1976
Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancerD Fritze, D H Kern, Y H PilchPageof 6